2024 High Conviction - Giant Biogene - Growth Rate Keeps Moving Higher
Giant Biogene was listed in Hong Kong IPO in 2022. It has done well since and is now trading 45% above its IPO price, but its still cheap.
423 Views
Consumer Staples: EM Managers Positioned at All-Time Lows
Consumer Staples allocations have fallen to their lowest levels in over a decade. A 5-year decline in Consumer Staples exposure was compounded by...
723 Views
CR Beer (291 HK) – 1H rev/EBIT +13%/26%; Heineken grew 60%
CR beer’s 13.6% 1H revenue growth comprised 9.0% beer revenue growth and RMB977mn baijiu revenue, which was reported and consolidated for the first...
241 Views
CR Beer (291 HK) – Expecting a Solid 1H23
1H23 operational performance came in largely in line with midsingle-digit volume growth, although that of 1Q was slightly stronger than 2Q due to...
185 Views
CR Beer (291 HK) – A Crowded Trade but Worthy of a Revisit for a Potentially Strong Summer Sales
CR Beer’s share price corrected by c.10% on softer-than-expected April sales. However, our channel check suggests steadfast 4M sales growth that...
386 Views